CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project investigates genetic factors contributing to Alzheimer's disease, focusing on identifying new molecular pathways and drug targets. By integrating genetic and imaging data, it aims to enhance clinical trial designs and improve predictions for disease progression.
Alzheimer’s disease (AD) is a major societal challenge, impacting up to one third of the population over 85 years old.
The European Commission and various international bodies have repeatedly fostered research initiatives to prevent the development or stem the progression of the disease.
Several recent phase 3 clinical trials have failed to show any efficacy in slowing disease progression, calling into question the current drug targets.
This project will use genetic data to identify new AD-relev…
INSTITUT DU CERVEAU ET DE LA MOELLE EPINIERE
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
United States, Stanford
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
